Continuous Glucose Monitoring (CGM) Sensors Market Size, Share, Growth, and Industry Analysis, By Type (Noninvasive Sensing, Minimally Invasive Sensing), By Application (Home Care, Hospital, Others), Regional Insights and Forecast to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

CONTINUOUS GLUCOSE MONITORING (CGM) SENSORS MARKET OVERVIEW

The global Continuous Glucose Monitoring (CGM) Sensors Market size estimated at USD 8.2 billion in 2026 and is projected to reach USD 38.75 billion by 2035, growing at a CAGR of 18.84% from 2026 to 2035.

The Continuous Glucose Monitoring (CGM) Sensors Market has expanded rapidly due to the growing diabetic population, broader adoption of digital health systems, and improved sensor accuracy. In 2025, more than 589 million people globally were living with diabetes, while over 541 million adults showed impaired glucose tolerance, increasing demand for continuous monitoring technologies. CGM sensors operate through automated glucose readings taken every 1 to 5 minutes, producing up to 288 measurements per day for a single user. Sensor wear duration improved from 7 days to 15 days across major commercial platforms. More than 68% of CGM users preferred mobile-connected monitoring systems, and nearly 74% of installations occurred outside conventional clinical environments.

The United States remains the most developed market for Continuous Glucose Monitoring (CGM) Sensors with strong adoption across insulin-dependent and non-insulin-dependent populations. In 2025, the country accounted for approximately 41% of global CGM sensor utilization. More than 38 million individuals in the United States live with diabetes, while approximately 98 million adults show prediabetic conditions. CGM penetration among insulin users exceeded 52%, compared with 18% among non-insulin-treated populations. More than 82% of endocrinology practices incorporated CGM interpretation into routine care, and over 63% of CGM users accessed data through smartphone-integrated platforms.

KEY FINDINGS

LATEST TRENDS

Continuous Glucose Monitoring (CGM) Sensors Market trends indicate increasing preference for compact, longer-duration, and software-integrated monitoring platforms. In 2025, more than 72% of newly introduced CGM systems supported smartphone-based display without dedicated receivers. Sensor accuracy continued to improve, with mean absolute relative difference values approaching 8% in premium models. Wear duration reached 15 days for several commercial offerings, reducing replacement frequency by approximately 50% compared with earlier generations.

Factory-calibrated sensors became dominant, reducing fingerstick confirmation frequency by over 80% for routine use. Automated alerts for hypoglycemia and hyperglycemia recorded engagement rates above 61% among active users. Integration with insulin delivery systems expanded, with nearly 39% of advanced users adopting connected diabetes management ecosystems.

MARKET DYNAMICS

Driver

Rising demand for diabetes management and real-time glucose tracking.

The primary growth factor in the Continuous Glucose Monitoring (CGM) Sensors Market is the increasing global burden of diabetes and expanding awareness regarding continuous monitoring benefits. In 2025, diabetes affected 589 million individuals globally, creating sustained demand for long-duration glucose tracking technologies. Continuous monitoring generated up to 288 daily readings, enabling stronger glucose pattern identification compared with traditional episodic testing methods. Studies reported that CGM adoption reduced time spent in hypoglycemic conditions by 27% and improved average monitoring adherence by 33%.

Restraint

High device maintenance requirements and reimbursement limitations.

Despite strong adoption, several barriers continue affecting Continuous Glucose Monitoring (CGM) Sensors Market expansion. Sensor replacement remains necessary every 10 to 15 days for most commercial products, increasing user burden. Approximately 31% of patients reported reimbursement-related limitations affecting long-term usage decisions. Training requirements also remain significant. Around 22% of first-time users experienced onboarding difficulties during initial implementation. Sensor detachment and skin irritation affected approximately 14% of users annually.

Expansion of personalized digital healthcare ecosystems

Opportunity

Continuous Glucose Monitoring (CGM) Sensors Market opportunities continue to expand through connected healthcare platforms and preventive care initiatives. Digital health engagement increased by 48% among diabetes patients using mobile monitoring solutions. Integration of predictive analytics improved glucose event forecasting accuracy by approximately 29%.

Home-based monitoring continues to strengthen opportunities because 67% of users prefer remote glucose observation over repeated clinical visits. Sensor miniaturization reduced average insertion depth and improved comfort metrics by more than 24%.

Balancing accuracy, affordability, and large-scale accessibility

Challenge

Maintaining sensor accuracy while reducing operating complexity remains a central challenge. Accuracy improvements require advanced enzyme chemistry and sensor stabilization methods, increasing production complexity. Around 18% of users reported concerns regarding occasional signal interruption.

Battery performance remains another challenge, with active transmission reducing operational efficiency during extended monitoring periods. Sensor lifespan targets exceeded 15 days in development pipelines, yet maintaining precision beyond this period remains technically difficult.

•   
•   
  

  Download Free Sample to learn more about this report

    

CONTINUOUS GLUCOSE MONITORING (CGM) SENSORS MARKET SEGMENTATION

By Type

• Noninvasive Sensing: Noninvasive sensing accounted for approximately 12% of Continuous Glucose Monitoring (CGM) Sensors Market deployment in 2025. This category focuses on optical, electromagnetic, and transdermal approaches without subcutaneous insertion. Development activity increased significantly, with prototype accuracy improving by 21% during recent validation cycles. User preference surveys indicated that 63% of potential adopters favored needle-free alternatives. Sensor comfort scores exceeded traditional formats by approximately 34%, supporting expansion potential.

• Minimally Invasive Sensing: Minimally invasive sensing represented approximately 88% of Continuous Glucose Monitoring (CGM) Sensors Market usage. These systems use subcutaneous sensors with continuous interstitial glucose detection. More than 90% of commercially available CGM systems operate through this method. Wear duration improved to 15 days while average data capture exceeded 95% of monitoring time. Accuracy values approached single-digit error percentages in advanced systems. Smartphone-linked monitoring reached 71% among minimally invasive users, strengthening long-term adoption.

By Application

• Home Care: Home care represented approximately 67% of Continuous Glucose Monitoring (CGM) Sensors Market application volume. Remote monitoring reduced clinic visits by approximately 26% and improved glucose tracking frequency. More than 64% of users shared monitoring data with caregivers. Patient satisfaction exceeded 78% because automated alerts improved response times. Sensor portability and simplified onboarding supported rapid expansion across aging populations and chronic care users.

• Hospital: Hospital applications accounted for approximately 24% of Continuous Glucose Monitoring (CGM) Sensors Market usage. Continuous monitoring improved inpatient glucose tracking intervals and supported early intervention. More than 58% of endocrinology departments introduced digital glucose observation protocols. Data integration reduced manual testing frequency and supported centralized patient monitoring. Hospital utilization increased particularly in intensive care and postoperative management.

• Others: Other applications contributed approximately 9% of Continuous Glucose Monitoring (CGM) Sensors Market activity. These include ambulatory care, research institutions, sports performance monitoring, and specialty disease management environments. Research adoption increased by 17% due to real-time metabolic observation capabilities. Specialty clinics expanded sensor deployment through integrated patient management workflows and long-duration monitoring programs.

•   
•   
  Download Free Sample to learn more about this report

    

CONTINUOUS GLUCOSE MONITORING (CGM) SENSORS MARKET REGIONAL INSIGHTS

• North America

North America held approximately 43% of the Continuous Glucose Monitoring (CGM) Sensors Market in 2025. The region maintained leadership through strong diabetes screening programs, broad physician adoption, and high wearable acceptance. More than 41 million adults across the region lived with diabetes, while prediabetic populations exceeded 105 million individuals.

The United States represented the largest regional contributor, accounting for over 84% of North American CGM utilization. Sensor adoption among insulin-dependent patients exceeded 52%, while digital diabetes monitoring platforms recorded usage above 61%. Approximately 82% of endocrinology practices incorporated CGM interpretation into clinical decision workflows.

• Europe

Europe accounted for approximately 28% of the Continuous Glucose Monitoring (CGM) Sensors Market in 2025 and remained a major adoption center due to strong public healthcare systems and structured chronic disease management programs. More than 61 million adults across Europe lived with diabetes and monitoring compliance programs improved long-term sensor engagement.

Germany, the United Kingdom, France, Italy, and Spain collectively represented more than 72% of regional deployment. CGM integration into routine diabetes management exceeded 57% in specialized care environments. Home-based usage reached approximately 63%, while hospital utilization accounted for 27%.

• Asia-Pacific

Asia-Pacific represented approximately 21% of the Continuous Glucose Monitoring (CGM) Sensors Market and showed the fastest volume expansion due to increasing diabetes prevalence and healthcare digitization. More than 290 million adults across the region lived with diabetes in 2025, creating substantial demand for continuous monitoring technologies.

China, Japan, India, South Korea, and Australia accounted for more than 78% of regional CGM activity. Urban healthcare systems accelerated deployment through connected monitoring programs and expanded endocrinology services. Home care represented approximately 69% of regional applications because of rising self-management awareness.

• Middle East & Africa

Middle East & Africa accounted for approximately 8% of the Continuous Glucose Monitoring (CGM) Sensors Market in 2025 and continued to expand through urban healthcare development and increasing diabetes awareness. More than 82 million adults across the region were affected by diabetes-related conditions. The Gulf region represented approximately 56% of regional CGM deployment because of stronger healthcare infrastructure and greater wearable technology adoption.

South Africa and selected North African healthcare systems increased specialty diabetes monitoring capacity. Home care applications reached approximately 59%, while hospital deployment represented 31%. Digital monitoring adoption improved by 29% due to expanding telehealth services. Smartphone-based glucose monitoring exceeded 54% of active users.

LIST OF TOP CONTINUOUS GLUCOSE MONITORING (CGM) SENSORS COMPANIES

• Medtronics
• Abbott
• Senseonics
• WaveForm Technologies
• Echo Therapeutics Inc
• Arkal Medical
• Azurite Technologies
• Biorasis
• Calisto Medical
• DexCom Inc
• DirectSens GmbH
• EyeSense GmbH

List Of Top 2 Companies Market Share

• Abbott – approximately 38% market share supported by broad sensor deployment, extended wear capability, and high penetration across connected diabetes monitoring platforms.
• DexCom Inc – approximately 31% market share supported by strong physician adoption, advanced mobile integration, and large installed user base across home care applications.

INVESTMENT ANALYSIS AND OPPORTUNITIES

Investment activity in the Continuous Glucose Monitoring (CGM) Sensors Market accelerated due to expansion of wearable healthcare systems and demand for continuous diabetes management. Manufacturing facilities increased automation levels by approximately 22% to support higher sensor output and reduce production variability. Investment in sensor miniaturization expanded by 31%, with emphasis on reduced insertion depth and improved wear comfort.

Research programs targeting noninvasive monitoring increased by approximately 27%, reflecting interest in eliminating subcutaneous placement. Artificial intelligence integration attracted substantial development attention, with predictive analytics deployment increasing by 34%. Digital ecosystem partnerships expanded by 29% to improve data sharing and remote patient supervision.

NEW PRODUCT DEVELOPMENT

Product innovation in the Continuous Glucose Monitoring (CGM) Sensors Market focused on wear duration, sensor precision, connectivity, and user convenience. Sensor lifespan advanced to 15 days in leading commercial formats, reducing replacement frequency and improving user continuity. Factory calibration technology expanded significantly and reduced routine fingerstick confirmation requirements by more than 80%. Smartphone compatibility exceeded 74%, enabling direct glucose display and automated alerts.

Miniaturized insertion systems reduced user-reported discomfort by approximately 24%. Waterproof performance improved, supporting uninterrupted monitoring during exercise and daily activity. Manufacturers increased predictive functionality through machine learning tools capable of identifying glucose trend patterns before threshold events occurred. Data transmission reliability improved by 19%, reducing information gaps.

FIVE RECENT DEVELOPMENTS (2023–2025)

• In 2023, a leading manufacturer expanded sensor wear duration to 15 days, reducing annual replacement frequency by approximately 27%.
• In 2024, smartphone-only CGM access surpassed 70% across newly introduced device ecosystems, reducing dependence on dedicated receivers.
• In 2024, predictive glucose alert capability improved early event detection performance by approximately 29%.
• In 2025, manufacturing expansion initiatives increased annual sensor production capacity by approximately 18%.
• In 2025, factory-calibrated sensor adoption exceeded 57%, reducing calibration-related user interactions.

CONTINUOUS GLUCOSE MONITORING (CGM) SENSORS MARKET REPORT COVERAGE

This report evaluates the Continuous Glucose Monitoring (CGM) Sensors Market through detailed assessment of sensing technologies, application environments, regional deployment, competitive positioning, investment activity, and innovation pipelines. The study incorporates quantitative indicators related to diabetes prevalence, sensor usage frequency, wear duration, and digital healthcare adoption. Coverage includes analysis of minimally invasive and noninvasive sensing technologies along with application-level evaluation across home care, hospitals, and specialty environments.

Regional assessment spans North America, Europe, Asia-Pacific, and Middle East & Africa. The report examines device performance indicators including data capture rates exceeding 95%, sensor operation periods reaching 15 days, and smartphone connectivity above 69%. It also evaluates manufacturing developments, user retention trends, and digital ecosystem integration. Competitive analysis highlights concentration among major manufacturers and examines market share distribution, innovation strategies, and deployment expansion.